Absolute risk differences (ARDs) for development of cutaneous T-cell lymphoma after dupilumab use

Published: 29 December 2025| Version 1 | DOI: 10.17632/8ygxrjk28v.1
Contributor:
Sahithi Talasila

Description

Absolute risk differences (ARDs) for development of cutaneous T-cell lymphoma after dupilumab use, ages 18-59 and Absolute risk differences (ARDs) for development of cutaneous T-cell lymphoma after dupilumab use, ages ≥60

Files

Categories

Dermatology, Oncology, Cutaneous T-Cell Lymphoma

Licence